UK small-cap RNS · 9 Oct 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies

07:00

Pristine Capital PRIS £0.7m
Annual Report Results
Annual report and accounts for the period ended 30 October 2025

+0.0% on the day
07:00

Pristine Capital PRIS £0.7m
Half-year Results Results
Interim loss widened to £170,905 from £98,902 as creditor negotiation costs rose; cash fell to £178,536 and net liabilities reached £252,579, leaving the shell dependent on a recapitalisation.

Cash shell / net cash above market value £0.5m · 71% of mcapoutlook mixedfirst since Oct 2023 +0.0% on the day

Moved: Funding and legal action: Abort fees unsettled; equity raise needed; deadline likely missed → Creditor deals agreed; fundraise awaits shareholder approval · Search for initial transaction: Remains a shell; no target → Still a shell; pending recapitalisation
07:00

Mcbride MCB £299m
2026 Annual Report and Accounts Results
The Company will today post the 2026 Annual Report to shareholders who have elected to receive communications in printed form.

+1.3% on the day
07:00

Genus GNS £1,504m
Annual Report and Annual General Meeting Results
Genus plc (LSE: GNS) announces that the following documents have been sent to shareholders:

+2.6% on the day
07:00

Scancell Holdings SCLP £124m
Final Results Results
Operating loss widened to £17.4m, no licence revenue after £4.7m last year, cash fell to £5.3m, and funding remains conditional on the merger closing.

Large acquisition / reverse takeover outlook mixedfirst in 8 months −1.1% on the day

Moved: iSCIB1+ melanoma registration path: BlackRock loan signed; EGM approval pending → Phase 3 set-up; start later in Q4 2026 · Neuphoria reverse merger: Merger agreed; conditions pending → Agreed; F-4 filing, vote and SEC review pending